Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of nicotinic acetylcholine receptor modulators. It serves as a structural building block in the development of drugs targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its rigid bicyclic framework enhances binding selectivity and metabolic stability in active compounds. Also employed in the preparation of chiral catalysts for asymmetric synthesis in medicinal chemistry research.